HK Stock Market Move | GENSCRIPT BIO (01548) rose over 5% again. Performance results will be announced in mid-March. Sales of CARVYKTI in the first half of the year increased significantly year-on-year.
Kingsoft Biotech (01548) rose over 5% again, and as of the time of publication, it has increased by 3.95%, trading at HKD 19.49, with a transaction volume of HKD 287 million.
GENSCRIPT BIO (01548) rose over 5% again, and as of the time of this report, it was up 3.95% at HKD 19.49, with a turnover of HKD 287 million.
In terms of news, GENSCRIPT BIO plans to hold a board meeting on August 15 to approve its interim results. The company previously announced that in the second quarter, sales of Legend Biologics' CARVYKTI reached USD 657 million, an increase of 49.4% year-on-year and a 10% increase quarter-on-quarter. For the first half of the year, sales reached USD 1.254 billion, an increase of 55.1% year-on-year.
Related Articles
US Stock Market Move | Optical communication concept stocks rise broadly, with Coherent (COHR.US) up over 7%.
SHANGHAI FUDAN (01385) plans to invest no more than 300 million yuan in subscribing to an industrial fund initiated by Guosheng Capital.
CONGYU INTE AGR(00875) plans to discount approximately 18.64% in the placement of up to 140 million shares, raising approximately 32.9 million Hong Kong dollars.
US Stock Market Move | Optical communication concept stocks rise broadly, with Coherent (COHR.US) up over 7%.
SHANGHAI FUDAN (01385) plans to invest no more than 300 million yuan in subscribing to an industrial fund initiated by Guosheng Capital.
CONGYU INTE AGR(00875) plans to discount approximately 18.64% in the placement of up to 140 million shares, raising approximately 32.9 million Hong Kong dollars.
RECOMMEND
